RankAlpha logo
Back to Rankings

BBOT

BridgeBio Oncology TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
BBOT vs peer average
15/100
BBOT vs. peer average (F vs. B)
Grade spread
A 2 · B 3 · C 1 · D 1 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

GYRE is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $722.09M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerGYREGyre Therapeutics
BBOT
BridgeBio Oncology Therapeutics
GYRE
Gyre Therapeutics
Grade
F
C
Momentum
7
61
Value
41
43
Sentiment
-
60
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs GYRE

BBOT / GYRE
Grade Position
Below peers
BBOT vs. peer average (F vs. B)
15/100
Momentum
7
GYRE
Value
41
GYRE
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BBOT
1
GYRE
Gyre Therapeutics Inc Common
C
60/100
-2
2
IRWD
Ironwood Pharmaceuticals Inc Class A Common
B
80/100
-3
3
ALLO
Allogene Therapeutics Inc Common
B
80/100
-3
4
NGNE
Neurogene Inc Common
F
20/100
Even
5
STTK
Shattuck Labs Inc Common
B
80/100
-3
GYRE is the first peer returned for this comparison set.